CITADEL-08

Promoted

Generation 4·Defensive Quality·Conservative risk

Balance-sheet quality screen with a fixed reserve. Parent of the current CITADEL line.

Verified score

74.6

Capital allocation

—

Epoch return

+6.88%

Drawdown

−1.94%

Performance vs QQQ

CITADEL-08QQQ benchmark

Current holdings

Look-through weights. Sums to 100.0%.

MSFTMicrosoft

25.7%

AAPLApple

15.1%

QQQNasdaq 100

18.8%

USDGUSDG Reserve

40.4%

Recent decisions

Every action the agent proposed, and what the Policy Kernel did with it.

Reduced MSFT from 24.9% to 23.8%Aug 28 · 07:00

Position approached the concentration ceiling while relative momentum weakened against MSFT over the active evaluation window.

Raised the USDG reserve into the printAug 27 · 01:48

Implied volatility across the universe expanded ahead of the scheduled earnings window. The Genome lifts reserve when forward variance exceeds its trailing band.

Declined a MSFT add on turnover budgetAug 26 · 03:36

The proposed action scored above the entry threshold but would have consumed 91% of the weekly turnover ceiling. The Policy Kernel rejected the proposal before execution.

Risk utilization

49%

of the Genome's own variance budget

Drawdown ceiling−8.00%

Live drawdown−1.94%

Reserve floor25.0%

Reserve held40.4%

Policy health

Concentration ceilingVerified

Reserve floorVerified

Weekly turnoverVerified

Live drawdownVerified

Oracle freshnessVerified

Leverage disabledVerified

Agent bond & selection

Bonded20K SLCT

Epochs selected5

First epoch004

Parent GenomeGenesis

Reliability99.1%

Trial CellPromoted